CONCORD
Start SIP
Invest Now
Start SIP in CONCORD
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
- 50 DMA₹79.10
- 100 DMA₹74.93
- 200 DMA₹65.70
Investment Returns
- Over 1 Month + 7.74%
- Over 3 Month -1.78%
- Over 6 Month + 61.41%
- Over 1 Year + 157.07%
Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!
Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Concord Drugs Financials
Concord Drugs Technicals
EMA & SMA
Current Price
₹86.58
+
2.63
(3.13%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹79.86
- 50 Day
- ₹79.10
- 100 Day
- ₹74.93
- 200 Day
- ₹65.70
Resistance and Support
85.64
- R3 91.26
- R2 89.56
- R1 87.34
- S1 83.42
- S2 81.72
- S3 79.50
Concord Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-14 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-07-03 | Preferential issue of shares | |
| 2025-06-27 | Preferential Issue of shares & Others | Inter-alia, to consider 1. the date, time, and venue for convening an ExtraOrdinary General Meeting of the Company. 2. Other business matters. |
Concord Drugs F&O
About Concord Drugs
- NSE Symbol
- CONCORD
- BSE Symbol
- 538965
- Chairman & Managing Director
- Mr. Sudhir Vaid
- ISIN
- INE858L01010
Similar Stocks to Concord Drugs
Concord Drugs FAQs
Concord Drugs share price is ₹86 As on 14 February, 2026 | 02:53
The Market Cap of Concord Drugs is ₹114.1 Cr As on 14 February, 2026 | 02:53
The P/E ratio of Concord Drugs is 198.2 As on 14 February, 2026 | 02:53
The PB ratio of Concord Drugs is 3 As on 14 February, 2026 | 02:53
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.